Floam Samantha, Simpson Norah, Nemeth Emese, Scott-Sutherland Jennifer, Gautam Shiva, Haack Monika
Harvard School of Dental Medicine, Boston, MA, USA.
Stanford University, Stanford, CA, USA.
J Sleep Res. 2015 Jun;24(3):296-304. doi: 10.1111/jsr.12259. Epub 2014 Dec 18.
This study investigates the extent to which sleep characteristics serve as predictor variables for inflammatory, hypothalamic-pituitary-adrenal and autonomic systems markers. Twenty-nine participants with a diagnosis of insomnia disorder based on the Diagnostic Statistical Manual of Mental Disorders, Fifth Edition (age 25.3 ± 1.6 years, insomnia duration 6.6 ± 0.8 years) and 19 healthy control sleepers (age 25.4 ± 1.4 years) underwent a 2-week at-home evaluation keeping a sleep diary and wearing an actigraph, followed by a visit to the Research Center to measure blood pressure, and collect blood and urine samples. The actigraphy- and diary-based variables of sleep duration, sleep-onset latency, wake after sleep onset and sleep fragmentation/number of night-time awakenings were averaged and entered as dependent variables in regression analyses. Composite scores were calculated for the autonomic (blood pressure, norepinephrine), inflammatory (monocyte counts, interleukin-6, C-reactive protein) and hypothalamic-pituitary-adrenal systems (cortisol), and used as predictor variables in regression models. Compared with controls, individuals with insomnia had a shorter sleep duration (P < 0.05), and a higher hypothalamic-pituitary-adrenal and inflammatory composite score (P < 0.05). The higher inflammatory score was mainly due to higher circulating monocytes (P < 0.05), rather than differences in interleukin-6 or C-reactive protein. In persistent insomnia disorder, cortisol is upregulated and associated with actigraphy- and diary-based wake after sleep onset, suggesting that wake after sleep onset may serve as a marker to identify individuals at increased risks for disorders associated with a hyperactive hypothalamic-pituitary-adrenal system. The absence of autonomic and pro-inflammatory changes (interleukin-6, C-reactive protein), despite a substantial decrease in actigraphic sleep duration, may relate to a higher resilience to the adverse biological consequences of insomnia in this young age group.
本研究调查了睡眠特征作为炎症、下丘脑 - 垂体 - 肾上腺及自主神经系统标志物预测变量的程度。29名根据《精神疾病诊断与统计手册》第五版诊断为失眠症的参与者(年龄25.3±1.6岁,失眠持续时间6.6±0.8年)和19名健康对照睡眠者(年龄25.4±1.4岁)进行了为期2周的居家评估,记录睡眠日记并佩戴活动记录仪,随后前往研究中心测量血压、采集血液和尿液样本。将基于活动记录仪和日记的睡眠持续时间、入睡潜伏期、睡眠中觉醒时间和睡眠片段化/夜间觉醒次数等变量进行平均,并作为回归分析中的因变量输入。计算自主神经系统(血压、去甲肾上腺素)、炎症系统(单核细胞计数、白细胞介素 - 6、C反应蛋白)和下丘脑 - 垂体 - 肾上腺系统(皮质醇)的综合评分,并用作回归模型中的预测变量。与对照组相比,失眠个体的睡眠持续时间较短(P<0.05),下丘脑 - 垂体 - 肾上腺和炎症综合评分较高(P<0.05)。较高的炎症评分主要是由于循环单核细胞增多(P<0.05),而非白细胞介素 - 6或C反应蛋白的差异。在持续性失眠症中,皮质醇上调并与基于活动记录仪和日记的睡眠中觉醒时间相关,这表明睡眠中觉醒时间可能作为一个标志物,用于识别下丘脑 - 垂体 - 肾上腺系统功能亢进相关疾病风险增加的个体。尽管活动记录仪记录的睡眠持续时间大幅减少,但自主神经系统和促炎变化(白细胞介素 - 6、C反应蛋白)未出现,这可能与该年轻年龄组对失眠不良生物学后果具有较高的恢复力有关。